Nicole Smith joins us and shares that after a transformative year she’s excited to be leading Evolab into it’s next decade of existence all the while innovating their product lines. We discuss goal setting in that rather than beginning with the end in mind, Nicole sets up the structure so that the means justify the ends. She describes it as a funnel. Whereas she did operate in a more linear fashion in years past, working in the cannabis industry doesn’t allow that luxury. Having to work through 5 banks, 3 Facebook pages, 15 credit card processors and 4 401K programs will wrest you from a linear mindset. Cannabis executives must continue to make progress in a linear fashion using circuitous routes.
Speaker 2: Nicole Smith joins us and shares that after a transformative year, she's excited to be leading evil lab into its next decade of existence. All the while innovating their product lines. We discussed goal setting in that rather than beginning with the end in mind. The sets up the structure so that the means justify the ends. She describes it as a funnel, whereas she did operate in a more linear fashion in the past. Working in the cannabis industry doesn't allow that luxury having to work through five banks, three facebook pages, 15 credit card processors, and for 401k programs will rescue from a linear mindset. Cannabis executives must continue to make progress in a linear fashion using circuitous routes. Welcome to cannabis economy. I'm your host Seth Adler. Check us out on social with the handle kanick economy. That's two ends of the word economy. Nicole Smith, you've always been a CEO, right? Always
Speaker 1: been the CEO. Yes. That has not changed. Meet the new boss. Same as the old boss, right? It's just a new place, a new place. Well, let's get it out of the way. What, uh, what's going on? Yeah, so I started with Eva lab, um, I guess the beginning of September, um, primarily because they were starting a new product line moving into medically focused products and I was available and said that they solicited me for awhile and it turned out that that was the right fit for me. Yeah. So you also have that experience. It's not that you were just available. No, I also had that experience. Yes. So where are they within their kind of a trajectory with product? Where are you coming into this, I guess? Right. So I'm evo has been around for quite a few years now, almost nine, primarily focused on, of course veep technologies.
Speaker 1: Um, see co two extraction, all the good stuff, right? No, PG, vg, all that kind of stuff. Right. So really high quality products, um, and mostly in the recreational market place and they had brought on a new scientist. I'm also very good friend of mine, um, a few months ago that had been working on some new products for them and when I was newly available then he mentioned to me that they were looking for maybe some additional leadership and we started talking and I said I would be happy to help him take the product line that he had developed and bring it to the marketplace. So a inter me now at evo. So their trajectory now is diversification of products and then also state expansion. State expansion, yes. We'll get to that in a second. Okay. Diversification of products. What are they set on? What are you thinking based on what they said, hey, we're going to do this, this and this.
Speaker 1: And you might've said, well, have you thought of that? But they. Yeah. So they had already started with um, sort of an innovative line of topical products. Um, obviously exploring some different capacities in the line of wellness vapes, which are really exciting. Um, I'm not sure if you're familiar, but there are a few companies that have been developing vape products. I'm using vitamin B 12 and some other ingredients. Like that, um, and so we'll be launching a line of vaporizers that incorporate not only cannabis but also other herbal ingredients, so very exciting stuff and it's a great transition product for them to take their technology from bape into a more of a wellness focus line and then a line of compatible products to that, which we might talk about it another time if I'm looking at your eyes, you know, so definitely topical. So there's a couple of topicals that are, be released immediately.
Become a member to access to webinars, quarterly reports, contributor columns, shows, excerpts, and complete podcast transcripts